“2023 Novel Drug Approvals Update”
Event Navigation
HealthTrust presents…“2023 Novel Drug Approvals CE Update”
Please Note: Continuing education credit is only available to those attending the session live. CE credit is not available when accessing the program on demand.
Each January, the FDA publishes a list of the drugs approved in the previous calendar year for human use. It’s important for pharmacists to know what these drugs are, how they’re to be used and be familiar with the clinical studies that support their use. The presenters will address the medications approved by the FDA in 2023 which are most likely to be seen in practice, summarize the clinical studies that support their use in the intended form(s), and identify clinical pearls for each medication.
Learning Objectives for Pharmacists, Healthcare Executives & Supply Chain | At the end of this session, participants should be able to:
- Recall the new molecular entities approved by the Food and Drug Administration (FDA) in 2023
- Recognize the indications and drug class of the new drugs
- Identify common adverse events, available dosage forms, and clinical pearls of the new drugs
Presenters:
Jessica Cook, PharmD, MHCI | Clinical Management PGY1 Fellow in Drug Information | Belmont University/HealthTrust
Zachary Fricker, PharmD | Clinical Pharmacist PGY1 Fellow in Drug Information | Belmont University/Aegis/FDA
Target Audience: Pharmacists, Healthcare Executives & Supply Chain professionals
CE Credit: Approved for Pharmacists, Healthcare Executives & Supply Chain professionals
This program is approved for CPEs by the Accreditation Council for Pharmacy Education (ACPE). Attendees of this program may earn 1.0 CPE Contact Hours. Belmont University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The Universal Activity Number for this activity is 0863-0000-24-007-L01-P. The activity is pending approval for 1 hour (.1 CEUs) of continuing education credit for Pharmacists who attend the webinar and complete the online evaluation. By attending the 2023 Novel Drug Approvals CE Update offered by
HealthTrust, participants may earn up to 1 ACHE Qualified Education Hours toward initial certification or recertification of the Fellow of the American College of Healthcare Executives (FACHE) designation.
Note about CE credit: If you plan to obtain credit for a live session, stay until the end of the presentation to receive the verification code you will need to obtain the continuing education credit. CE credit is individual. No group credit is available. Each person must register for a webinar and attend the webinar in its entirety in order to receive an email after the event with instructions on how to apply for continuing education credit. Attendees should not share the code or forward the email to others who did not actually attend the program. If they are not able to be verified on our webinar provider reports and registration list they will not receive credit. If you are joining only by phone, you will not be eligible for credit. You must also log in and join the visual portion of the webinar to be part of our CE provider-required reporting.
Registration details coming soon!
